Please wait a minute...
ISSN 1006-298X CN 32-1425/R
Adv Search
Home
About Journal
Editorial Board
Contribution
Journal
Accepted
Current Issue
Archive
Most Download
Most Read
Most Cited
E-mail Alert
RSS
Subscription
Advertising
Contact Us
中文
Journal
Current Issue
Accepted
Archive
Adv Search
Most Read
Most Download
Most Cited
E-mail Alert
RSS
WeChat
Current Issue
2026, 35 (4)
Previous Issue
Daratumumab combined with Dexamethasone in Mayo stage ⅢB systemic light⁃chain amyloidosis patients
HU Chenghui, GUO Jinzhou, CHEN Wencui, WU Xiaomei, XU Weiwei, HUANG Xianghua
2026, 35 (4): 301-306.
DOI:
10.3969/j.issn.1006⁃298X.2026.04.001
Abstract(
150
)
PDF (1551KB) (
75
)
Clinicopathological analysis of podocyte infolding glomerulopathy cases
HU Ruimin, WANG Yingzi, YANG Mengyuan, MA Gailing, ZHOU Sijie, XING Guolan
2026, 35 (4): 307-312.
DOI:
10.3969/j.issn.1006⁃298X.2026.04.002
Abstract(
188
)
PDF (1491KB) (
61
)
Prognostic value of dynamic absolute lymphocyte count trajectories for pneumocystis jirovecii pneumonia⁃associated acute respiratory distress syndrome in renal transplant recipients
FU Meng, WANG Yang, ZHENG Mingzhu, LIU Zhihong
2026, 35 (4): 313-320.
DOI:
10.3969/j.issn.1006⁃298X.2026.04.003
Abstract(
119
)
PDF (1312KB) (
56
)
Correlation analysis of dry weight and bone mineral density after total parathyroidectomy for secondary hyperparathyroidism
ZHAO Shasha, GAN Wei, ZHANG Liang, DAI Chunsun, XIONG Mingxia
2026, 35 (4): 321-326.
DOI:
10.3969/j.issn.1006⁃298X.2026.04.004
Abstract(
80
)
PDF (1185KB) (
41
)
Burden of type 2 diabetic kidney disease attributable to low physical activity in China from 1990 to 2023 and trend prediction
SONG Furong, XUE Haoyuan, YU Jianxing, WU Wei
2026, 35 (4): 327-333.
DOI:
10.3969/j.issn.1006⁃298X.2026.04.005
Abstract(
68
)
PDF (2807KB) (
30
)
Darbepoetin alfa for erythropoietin hyporesponsive anemia in hemodialysis patients
YANG Xi, GAO Erzhi, DONG Jianhua, WANG Qing, FAN Wenjing, LI Chuan, GE Yongchun
2026, 35 (4): 334-339.
DOI:
10.3969/j.issn.1006⁃298X.2026.04.006
Abstract(
169
)
PDF (911KB) (
40
)
Suboptimal serum phosphorus control in maintenance hemodialysis patients: a multicenter cross⁃sectional study
HAO Xinxin, LIZhongxin, GUO Yan, MA Yingchun, WANG Lei, DING Jiaxiang, REN Jianwei, et al
2026, 35 (4): 340-345.
DOI:
10.3969/j.issn.1006⁃298X.2026.04.007
Abstract(
156
)
PDF (915KB) (
48
)
Morphological characteristics guided percutaneous transluminal angioplasty for stenosis of autologous arteriovenous fistula
LI Hua
2026, 35 (4): 346-347.
DOI:
10.3969/j.issn.1006⁃298X.2026.04.008
Abstract(
71
)
PDF (843KB) (
36
)
Ultrasound⁃guided sharp recanalization strategy for occluded hemodialysis access
ZHAN Shen, et al
2026, 35 (4): 348-349.
DOI:
10.3969/j.issn.1006⁃298X.2026.04.009
Abstract(
73
)
PDF (829KB) (
58
)
Prevention of autologous arteriovenous fistula stenosis: strategies targeting vascular remodeling
DONG Jianhua
2026, 35 (4): 350-351.
DOI:
10.3969/j.issn.1006⁃298X.2026.04.010
Abstract(
59
)
PDF (725KB) (
37
)
Clinical practice guideline at a glance for the prevention and management of cardiovascular⁃kidney⁃metabolic syndrome
REN Guisheng, LIU Zhihong
2026, 35 (4): 352-356.
DOI:
10.3969/j.issn.1006⁃298X.2026.04.011
Abstract(
224
)
PDF (743KB) (
55
)
Advances in single⁃cell and spatial omics technologies for elucidating molecular alterations in renal cells of kidney diseases
LI Shuying, CHEN Qilin
2026, 35 (4): 357-362.
DOI:
10.3969/j.issn.1006⁃298X.2026.04.012
Abstract(
54
)
PDF (3443KB) (
33
)
Advances in mitochondrial DNA damage in diabetic kidney disease
GUO Yifan, YAN Xiaoru, LIU Jiani, YI Liang
2026, 35 (4): 363-368.
DOI:
10.3969/j.issn.1006⁃298X.2026.04.013
Abstract(
66
)
PDF (2441KB) (
46
)
B⁃cell targeted therapy in elderly patients with kidney diseases
LIU Ye, ZHANG Jiong
2026, 35 (4): 369-373.
DOI:
10.3969/j.issn.1006⁃298X.2026.04.014
Abstract(
56
)
PDF (738KB) (
41
)
Functional monitoring and maintenance of arteriovenous vascular access in hemodialysis
FAN Wenjing, GE Yongchun
2026, 35 (4): 374-379.
DOI:
10.3969/j.issn.1006⁃298X.2026.04.015
Abstract(
67
)
PDF (858KB) (
61
)
Anticoagulation strategies for continuous renal replacement therapy in patients with high bleeding risk
WANG Chen, LIU Kai, LI Zhiwei, ZHOU Yadong
2026, 35 (4): 380-384.
DOI:
10.3969/j.issn.1006⁃298X.2026.04.016
Abstract(
78
)
PDF (724KB) (
81
)
Research progress of sucroferric oxyhydroxide in hyperphosphatemia among patients with maintenance hemodialysis
YANG Tianmei, LI Guisen
2026, 35 (4): 385-389.
DOI:
10.3969/j.issn.1006⁃298X.2026.04.017
Abstract(
87
)
PDF (1290KB) (
67
)
Nephrotic syndrome secondary to Lenvatinib therapy
CAO Jing, WEI Qing, GONG Yuxiang, YANG Minyu, ZHANG Xiaoliang, WU Min
2026, 35 (4): 390-394.
DOI:
10.3969/j.issn.1006⁃298X.2026.04.018
Abstract(
108
)
Hematuria as the initial symptom of type I renal hypouricemia
LU Huiqing, XU Changsheng, LYU Qiang, HUANG Zhiyong, SHEN Shuqiong
2026, 35 (4): 395-399.
DOI:
10.3969/j.issn.1006⁃298X.2026.04.019
Abstract(
68
)
PDF (1947KB) (
53
)
